|
|
|
|
|
Enfuvirtide Acetate |
|
C204H301N51O64 |
|
159519-65-0 |
|
It is applicable to the treat chronic human immunodeficiency virus infection of adults and children over 6 years old. |
|
Parameters of Product: 1 .Appearance :White powder 2 .Water Content(Karl Fischer) :ЎВ5.0% 3 .Acetate Content(by HPLC) :ЎВ10.0% 4 .Amino Acid Composition :Ўѕ15% of theoretical 5 .Purity (by HPLC) :ЎГ95.0% 6 .Single Impurity(by HPLC) :ЎВ2.0% 7 .Peptide Content(by %N) :ЎГ80% 8 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0% 9 .Bacterial Endotoxins :ЎВ5EU/mg
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|